Delia Colombo, Luca Bianchi, Gabriella Fabbrocini, Salvatore Corrao, Annamaria Offidani, Luca Stingeni, Antonio Costanzo, Giovanni Pellacani, Ketty Peris, Federico Bardazzi, Giuseppe Argenziano, Silvana Ruffolo, Paolo Dapavo, Carlo Carrera, Maria Concetta Fargnoli, Aurora Parodi, Marco Romanelli, Piergiorgio Malagoli, Alessandro Zullo, Fabio Ferri, Martina Fiocchi, Emanuela Zagni
Issues - Giugno 2022
Delia Colombo, Luca Bianchi, Gabriella Fabbrocini, Salvatore Corrao, Annamaria Offidani, Luca Stingeni, Antonio Costanzo, Giovanni Pellacani, Ketty Peris, Federico Bardazzi, Giuseppe Argenziano, Silvana Ruffolo, Paolo Dapavo, Carlo Carrera, Maria Concetta Fargnoli, Aurora Parodi, Marco Romanelli, Piergiorgio Malagoli, Alessandro Zullo, Fabio Ferri, Martina Fiocchi, Emanuela Zagni
JJ Wu, A Kavanaugh, MG Lebwohl, R Gniadecki, JF Merola
Psoriasis and metabolic syndrome: implications for the management and treatment of psoriasis
J Eur Acad Dermatol Venereol. 2022 Jun;36(6):797-806M Gooderham, A Pinter, LK Ferris, RB Warren, T Zhan, J Zeng, AM Soliman, C Kaufmann, B Kaplan, H Photowala, B Strober
Long-term, durable, absolute Psoriasis Area and Severity Index and health-related quality of life improvements with risankizumab treatment: a post hoc integrated analysis of patients with moderate-to-severe plaque psoriasis
J Eur Acad Dermatol Venereol. 2022 Jun;36(6):855-865A Bregnhøj, KKH Thuesen, T Emmanuel, T Litman, CL Grek, GS Ghatnekar, C Johansen, L Iversen
HSP90 inhibitor RGRN-305 for oral treatment of plaque-type psoriasis: efficacy, safety and biomarker results in an open-label proof-of-concept study
Br J Dermatol. 2022;186: 861-874Hideaki Miyachi, Takaaki Konishi, Ryosuke Kumazawa, Hiroki Matsui, Sayuri Shimizu, Kiyohide Fushimi, Hiroyuki Matsue, Hideo Yasunaga
Treatments and outcomes of generalized pustular psoriasis: A cohort of 1516 patients in a nationwide inpatient database in Japan
JAAD 2022;86(6):1266-1274Inger Marie Skoie, Kjetil Bårdsen, Mari M Nilsen, Live E. Eidem, Tore Grimstad, Ingvild Dalen, Roald Omdal
Fatigue and expression of heat-shock protein genes in plaque psoriasis
CED 2022; 47(6):1068-1077Cæcilie Bachdal Johansen, Alexander Egeberg, Espen Jimenez-Solem, Lone Skov, Simon Francis Thomsen
Association of maternal psoriasis and small for gestational age or preterm birth: a nationwide matched cohort study in 69.080 singleton infants
CED 2022;47(6):1115-1123Wafaa A. Shehata, Mostafa A. Hammam, Rasha S. Enany, Sally M. El-Hefnawy, Shimaa Abdelsattar
Uncoupling protein 2 and dynamin-related protein 1 mRNA expressions as genetic markers for plaque psoriasis
IJD 2022; 61(6):710-717Bruno Halioua, Clara Chelli, Laurent Misery, Jonathan Taieb, Charles Taieb
Sleep disorders and psoriasis: An update
Acta Derm Venereol. 2022 Apr 27;102:adv00699Michael S. Garshick, Kamelia Drenkova, Tessa J. Barrett, Florencia Schlamp, Edward A. Fisher, Stuart Katz, Sanja Jelic, Andrea L. Neimann, Jose U. Scher, James Krueger, Jeffrey S. Berger
A randomized open-label clinical trial of lipid-lowering therapy in psoriasis to reduce vascular endothelial inflammation
J Invest Dermatol. 2022 Jun;142(6):1749-1752Hsien-Yi Chiu, Yi-Teng Hung, Shi-Wei Huang, Yu-Huei Huang
Comparative risk of herpes zoster in patients with psoriatic disease on systemic treatments: a systematic review and network meta-analysis
Ther Adv Chronic Dis. 2022 May 2;13:20406223221091188.S Chabra, B J Gill, G Gallo, D Zhu, C Pitou, C D Payne, A Accioly, L Puig
Ixekizumab citrate-free formulation: Results from two clinical trials
Adv Ther. 2022 Apr 21;1-11V Di Lernia, L Macca, L Peterle, Y Ingrasciotta, G Trifirò, C Guarneri